Literature DB >> 30733303

Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury.

William Bain1, Tolani Olonisakin1, Minting Yu1, Yanyan Qu1, Mei Hulver1, Zeyu Xiong1, Huihua Li1, Joseph Pilewski1, Rama K Mallampalli1,2, Mehdi Nouraie1, Anuradha Ray1, Prabir Ray1, Zhenyu Cheng3, Robert M Q Shanks4, Claudette St Croix5, Roy L Silverstein6, Janet S Lee1,7.   

Abstract

Thrombocytopenia is associated with worse outcomes in patients with acute respiratory distress syndrome, which is most commonly caused by infection and marked by alveolar-capillary barrier disruption. However, the mechanisms by which platelets protect the lung alveolar-capillary barrier during infectious injury remain unclear. We found that natively thrombocytopenic Mpl -/- mice deficient in the thrombopoietin receptor sustain severe lung injury marked by alveolar barrier disruption and hemorrhagic pneumonia with early mortality following acute intrapulmonary Pseudomonas aeruginosa (PA) infection; barrier disruption was attenuated by platelet reconstitution. Although PA infection was associated with a brisk neutrophil influx, depletion of airspace neutrophils failed to substantially mitigate PA-triggered alveolar barrier disruption in Mpl -/- mice. Rather, PA cell-free supernatant was sufficient to induce lung epithelial cell apoptosis in vitro and in vivo and alveolar barrier disruption in both platelet-depleted mice and Mpl -/- mice in vivo. Cell-free supernatant from PA with genetic deletion of the type 2 secretion system, but not the type 3 secretion system, mitigated lung epithelial cell death in vitro and lung injury in Mpl -/- mice. Moreover, platelet releasates reduced poly (ADP ribose) polymerase cleavage and lung injury in Mpl -/- mice, and boiling of platelet releasates, but not apyrase treatment, abrogated PA supernatant-induced lung epithelial cell cytotoxicity in vitro. These findings indicate that while neutrophil airspace influx does not potentiate infectious lung injury in the thrombocytopenic host, platelets and their factors protect against severe pulmonary complications from pathogen-secreted virulence factors that promote host cell death even in the absence of overt infection.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2019        PMID: 30733303      PMCID: PMC6373758          DOI: 10.1182/bloodadvances.2018026286

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  81 in total

Review 1.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

2.  Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia.

Authors:  M Bachofen; E R Weibel
Journal:  Am Rev Respir Dis       Date:  1977-10

3.  Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice.

Authors:  Angèle Gros; Varouna Syvannarath; Lamia Lamrani; Véronique Ollivier; Stéphane Loyau; Tobias Goerge; Bernhard Nieswandt; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

4.  A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.

Authors:  Yongyue Wei; Paula Tejera; Zhaoxi Wang; Ruyang Zhang; Feng Chen; Li Su; Xihong Lin; Ednan K Bajwa; B Taylor Thompson; David C Christiani
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 5.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

6.  Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.

Authors:  W S Alexander; A W Roberts; N A Nicola; R Li; D Metcalf
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

7.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.

Authors:  Mark R Looney; John X Nguyen; Yongmei Hu; Jessica A Van Ziffle; Clifford A Lowell; Michael A Matthay
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

8.  Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism.

Authors:  Christopher E Jenkins; Ania Swiatoniowski; Andrew C Issekutz; Tong-Jun Lin
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.486

9.  Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury.

Authors:  Y Zhao; Z Xiong; E J Lechner; P A Klenotic; B J Hamburg; M Hulver; A Khare; T Oriss; N Mangalmurti; Y Chan; Y Zhang; M A Ross; D B Stolz; M R Rosengart; J Pilewski; P Ray; A Ray; R L Silverstein; J S Lee
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

10.  Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance.

Authors:  Connie H Y Wong; Craig N Jenne; Björn Petri; Navina L Chrobok; Paul Kubes
Journal:  Nat Immunol       Date:  2013-06-16       Impact factor: 25.606

View more
  8 in total

1.  Lung megakaryocytes display distinct transcriptional and phenotypic properties.

Authors:  Anthony K Yeung; Carlos Villacorta-Martin; Stephanie Hon; Jason R Rock; George J Murphy
Journal:  Blood Adv       Date:  2020-12-22

Review 2.  The matricellular protein thrombospondin-1 in lung inflammation and injury.

Authors:  Mohammadreza Tabary; Atish Gheware; Hernán F Peñaloza; Janet S Lee
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

Review 3.  Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation.

Authors:  Nadine Ludwig; Annika Hilger; Alexander Zarbock; Jan Rossaint
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

4.  Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.

Authors:  Jill Zupetic; Hernán F Peñaloza; William Bain; Mei Hulver; Roberta Mettus; Peter Jorth; Yohei Doi; Jennifer Bomberger; Joseph Pilewski; Mehdi Nouraie; Janet S Lee
Journal:  Chest       Date:  2021-04-17       Impact factor: 9.410

5.  Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.

Authors:  Guadalupe Ortiz-Muñoz; Michelle A Yu; Emma Lefrançais; Beñat Mallavia; Colin Valet; Jennifer J Tian; Serena Ranucci; Kristin M Wang; Zhe Liu; Nicholas Kwaan; Diana Dawson; Mary Ellen Kleinhenz; Fadi T Khasawneh; Peter M Haggie; Alan S Verkman; Mark R Looney
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

6.  Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.

Authors:  William Bain; Huihua Li; Rick van der Geest; Sara R Moore; Tolani F Olonisakin; Brian Ahn; Erin Papke; Kaveh Moghbeli; Rebecca DeSensi; Sarah Rapport; Melissa Saul; Mei Hulver; Zeyu Xiong; Rama K Mallampalli; Prabir Ray; Alison Morris; Lina Ma; Yohei Doi; Yingze Zhang; Georgios D Kitsios; Hrishikesh S Kulkarni; Bryan J McVerry; Viviana P Ferreira; Mehdi Nouraie; Janet S Lee
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

Review 7.  Pseudomonas Aeruginosa Induced Cell Death in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Rushikesh Deshpande; Chunbin Zou
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

8.  Platelets modulate multiple markers of neutrophil function in response to in vitro Toll-like receptor stimulation.

Authors:  Kathryn E Hally; Georgina K Bird; Anne C La Flamme; Scott A Harding; Peter D Larsen
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.